EA201400806A1 - Фармацевтические композиции для местного применения, содержащие бексаротен и кортикостероиды - Google Patents

Фармацевтические композиции для местного применения, содержащие бексаротен и кортикостероиды

Info

Publication number
EA201400806A1
EA201400806A1 EA201400806A EA201400806A EA201400806A1 EA 201400806 A1 EA201400806 A1 EA 201400806A1 EA 201400806 A EA201400806 A EA 201400806A EA 201400806 A EA201400806 A EA 201400806A EA 201400806 A1 EA201400806 A1 EA 201400806A1
Authority
EA
Eurasian Patent Office
Prior art keywords
pharmaceutical compositions
bexaroten
corticosteroids
local application
application containing
Prior art date
Application number
EA201400806A
Other languages
English (en)
Inventor
Фритьоф Эверс
Забине Фильхауэр
Хеннинг Малльвитц
Хаген Троммер
Кристоф Виллерс
Original Assignee
Альмираль, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48781060&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EA201400806(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP12000077.3A external-priority patent/EP2612665A1/en
Application filed by Альмираль, С.А. filed Critical Альмираль, С.А.
Publication of EA201400806A1 publication Critical patent/EA201400806A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

В заявке описаны фармацевтические композиции для местного применения, которые включают: а) бексаротен, б) кортикостероид и в) носитель или наполнитель. Указанные композиции пригодны для лечения кожных нарушений.
EA201400806A 2012-01-09 2012-12-18 Фармацевтические композиции для местного применения, содержащие бексаротен и кортикостероиды EA201400806A1 (ru)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP12000077.3A EP2612665A1 (en) 2012-01-09 2012-01-09 Topical pharmaceutical compositions comprising bexarotene and a corticosteroide
US201261585786P 2012-01-12 2012-01-12
US201261598095P 2012-02-13 2012-02-13
EP12000909 2012-02-13
PCT/EP2012/005237 WO2013104399A1 (en) 2012-01-09 2012-12-18 Topical pharmaceutical compositions comprising bexarotene and a corticosteroids

Publications (1)

Publication Number Publication Date
EA201400806A1 true EA201400806A1 (ru) 2015-02-27

Family

ID=48781060

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201400806A EA201400806A1 (ru) 2012-01-09 2012-12-18 Фармацевтические композиции для местного применения, содержащие бексаротен и кортикостероиды

Country Status (21)

Country Link
US (1) US20140349981A1 (ru)
EP (1) EP2802321A1 (ru)
JP (1) JP2015503573A (ru)
KR (1) KR20140107370A (ru)
CN (1) CN104053437A (ru)
AU (1) AU2012365658A1 (ru)
BR (1) BR112014015578A8 (ru)
CA (1) CA2857207A1 (ru)
CL (1) CL2014001776A1 (ru)
CO (1) CO7000772A2 (ru)
CR (1) CR20140326A (ru)
EA (1) EA201400806A1 (ru)
GT (1) GT201400146A (ru)
HK (1) HK1198423A1 (ru)
IL (1) IL232765A0 (ru)
MX (1) MX2014007300A (ru)
PE (1) PE20142375A1 (ru)
PH (1) PH12014501573A1 (ru)
SG (1) SG11201403762PA (ru)
WO (1) WO2013104399A1 (ru)
ZA (1) ZA201403483B (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4083029A1 (en) 2013-08-20 2022-11-02 University of Washington through its Center for Commercialization Novel and specific inhibitors of cytochrome p450 26 retinoic acid hydroxylase
WO2016205001A1 (en) 2015-06-18 2016-12-22 Valeant Pharmaceuticals North America Topical compositions comprising a corticosteroid and a retinoid for treating psoriasis
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
CN113453670A (zh) * 2018-09-28 2021-09-28 乔·斯图丁 类固醇和大分子的透孔递送
WO2020084548A1 (en) * 2018-10-26 2020-04-30 Viramal Limited Mucoadhesive gel composition

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4387463B2 (ja) 1997-02-20 2009-12-16 アラーガン、インコーポレイテッド タザロテンおよびコルチコステロイドによる乾癬の処置
CN1210034C (zh) * 2002-12-06 2005-07-13 重庆华邦制药股份有限公司 治疗银屑病的药物组合物
CN1210035C (zh) 2003-09-29 2005-07-13 中国医学科学院皮肤病研究所 治疗银屑病的复方外用药物

Also Published As

Publication number Publication date
JP2015503573A (ja) 2015-02-02
EP2802321A1 (en) 2014-11-19
PE20142375A1 (es) 2015-01-11
US20140349981A1 (en) 2014-11-27
CA2857207A1 (en) 2013-07-18
WO2013104399A1 (en) 2013-07-18
BR112014015578A8 (pt) 2017-07-04
IL232765A0 (en) 2014-07-31
BR112014015578A2 (pt) 2017-06-13
HK1198423A1 (en) 2015-04-24
CR20140326A (es) 2015-01-16
CL2014001776A1 (es) 2014-08-29
CN104053437A (zh) 2014-09-17
CO7000772A2 (es) 2014-07-21
GT201400146A (es) 2015-10-12
KR20140107370A (ko) 2014-09-04
AU2012365658A1 (en) 2014-07-03
PH12014501573A1 (en) 2014-10-08
ZA201403483B (en) 2015-06-24
SG11201403762PA (en) 2014-07-30
MX2014007300A (es) 2014-07-28

Similar Documents

Publication Publication Date Title
PH12019502269A1 (en) Quinazoline derivatives for the treatment of viral infections and further diseases
EA201591166A1 (ru) Ингибиторы аутотаксина
EA201991484A1 (ru) Лекарственные формы энзалутамида
EA201391106A1 (ru) Новые гетероциклические производные
EA201991772A1 (ru) Способ лечения рака предстательной железы с использованием комбинации на основе модулятора андрогенного рецептора
EA201690881A1 (ru) Соединения-ингибиторы аутотаксина
EA201691070A1 (ru) Новые трициклические соединения в качестве противораковых средств
EA201691079A1 (ru) Комбинированная терапия для лечения онкологического заболевания
EA201400976A1 (ru) Бензодиоксаны в комбинации с другими активными средствами для ингибирования продуцирования лейкотриена
EA201591746A1 (ru) Способы и композиции для ингибирования бромодомен-содержащих белков
EA201590590A1 (ru) Модуляторы рецептора андрогенов и их применение
BR112015001847A2 (pt) composições e tratamento para doenças e distúrbios nos olhos
EA201591404A1 (ru) Спиролактамные модуляторы рецептора nmda и их применение
EA201691293A1 (ru) Гетероарильные производные бутановой кислоты в качестве ингибиторов lta4h
EA201692109A1 (ru) Варианты антител к фактору d и их применение
MX2014010537A (es) Moduladores de receptor x del higado (lxr) para el tratamiento de enfermedades, trastornos y condiciones dermicas.
PH12016500978A1 (en) Piperazine derivatives having multimodal activity against pain
PH12014502032A1 (en) Treatment of brain cancer
EA201690039A1 (ru) Ингибиторы rorc2 и способы их применения
TR201910866T4 (tr) Kanser tedavisi için birleşik preparasyonlar.
EA201400806A1 (ru) Фармацевтические композиции для местного применения, содержащие бексаротен и кортикостероиды
EA201690880A1 (ru) Тетрациклические ингибиторы аутотаксина
EA201792571A1 (ru) Терапевтическое применение l-4-хлорокинуренина
EA201691108A1 (ru) Хиназолин-thf-амины в качестве ингибиторов pde1
MX2016002930A (es) Moduladores del receptor x hepatico (lxr).